Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 101, 103979
Abstract
No abstract availableKeywords
Funding Information
- KFUPM (SB191017)
This publication has 29 references indexed in Scilit:
- Inhibitory kinetics and mechanism of kaempferol on α-glucosidaseFood Chemistry, 2016
- Triazine as a promising scaffold for its versatile biological behaviorEuropean Journal of Medicinal Chemistry, 2015
- Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic reviewExpert Review of Pharmacoeconomics & Outcomes Research, 2015
- Triazinoindole analogs as potent inhibitors of α-glucosidase: Synthesis, biological evaluation and molecular docking studiesBioorganic Chemistry, 2015
- Endothelial nitric oxide synthase (eNOS) 4b/a polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus: A meta-analysisMeta Gene, 2014
- 1-Phenyl-1H- and 2-phenyl-2H-1,2,3-triazol derivatives: Design, synthesis and inhibitory effect on alpha-glycosidasesEuropean Journal of Medicinal Chemistry, 2014
- Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivativesBioorganic & Medicinal Chemistry, 2013
- Inhibition of α-glucosidase and α-amylase by diaryl derivatives of imidazole-thione and 1,2,4-triazole-thiolEuropean Journal of Medicinal Chemistry, 2011
- Synthesis and antitumor activity of new 1,2,4‐triazine and [1,2,4]triazolo[4,3‐b][1,2,4]triazine derivatives and their thioglycoside and acyclic C‐nucleoside analogsJournal of Heterocyclic Chemistry, 2010
- Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitorsBioorganic & Medicinal Chemistry, 2010